Journal article icon

Journal article

Development of cancer metabolism as a therapeutic target: New pathways, patient studies, stratification and combination therapy

Abstract:
Cancer metabolism has undergone a resurgence in the last decade, 70 years after Warburg described aerobic glycolysis as a feature of cancer cells. A wide range of techniques have elucidated the complexity and heterogeneity in preclinical models and clinical studies. What emerges are the large differences between tissues, tumour types and intratumour heterogeneity. However, synergies with inhibition of metabolic pathways have been found for many drugs and therapeutic approaches, and a critical role of window studies and translational trial design is key to success.
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Files:
Publisher copy:
10.1038/s41416-019-0666-4

Authors


More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Oncology
Oxford college:
St Hugh's College
Role:
Author
ORCID:
0000-0003-1376-8409


Publisher:
Springer Nature
Journal:
British Journal of Cancer More from this journal
Volume:
122
Pages:
1-3
Publication date:
2019-12-10
Acceptance date:
2019-11-12
DOI:
EISSN:
1532-1827
ISSN:
0007-0920
Pmid:
31819198


Language:
English
Keywords:
Pubs id:
1078117
Local pid:
pubs:1078117
Deposit date:
2020-08-20

Terms of use



Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP